![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
20
Artemis Biotech (a Division Of Themis Medicare Limited) Hyderabad In, based in India, is a pharmaceutical company.
One of their significant offerings is Simvastatin, Antioxidant Butylated Hydroxy Toluene 0.01%, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2003-257 - Rev 06
This Chemical Type CEP, issued on November 21, 2019, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1563 associated with this CEP further emphasizes